Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XYLOMETAZOLINE vs ZANAMIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

XYLOMETAZOLINE vs ZANAMIVIR: Safety Overview

Metric XYLOMETAZOLINE ZANAMIVIR
Total FAERS Reports 539 384
Deaths Reported 217 123
Death Rate 40.3% 32.0%
Hospitalizations 254 112
Average Patient Age 70.4 yrs 38.4 yrs
% Female Patients 26.7% 49.8%
FDA Approval Date N/A Jul 26, 1999
Manufacturer Lydia Co., Ltd. GlaxoSmithKline LLC
Route NASAL RESPIRATORY (INHALATION)
Marketing Status N/A Prescription